Dosing: The Three Ways It Goes Wrong—Too Much, Too Little, and the Timing That Pretends It Doesn’t Matter
There are two kinds of dosing confusion: the kind that comes from misunderstanding a label, and the kind that comes […]
When AI Gets Your Drug Wrong: The Hidden Risk of Outdated Training Data in Pharma AI Responses
In March 2023, the FDA updated the prescribing information for Dupixent (dupilumab) to include new warnings around eosinophilic conditions. Physicians
What ChatGPT Gets Wrong About Drug Safety in Pregnancy — And Why Pharma Should Care
A pregnant patient searches ‘is it safe to take metformin while pregnant’ in ChatGPT. The answer she receives is plausible,
Pharma’s Blind Spot: How AI Citation Sources Are Reshaping Drug Brand Risk
When a patient asks ChatGPT whether Ozempic causes pancreatitis, the answer they receive depends entirely on which sources the model
When AI Gets Clinical Trials Wrong: What Pharma Brand Teams Must Monitor Now
A physician in Cincinnati asks ChatGPT whether semaglutide reduces cardiovascular events in patients without diabetes. The AI answers confidently, citing
Pharma Brand Protection in the Age of AI: Monitor LLMs Before They Monitor You
Every day, millions of patients type questions about their prescriptions into ChatGPT, Perplexity, Gemini, and Claude. They ask whether Ozempic
Inside AEO for Pharma: The Tools Watching What ChatGPT Says About Your Drug
A patient with rheumatoid arthritis does not always call her rheumatologist first anymore. She opens ChatGPT and asks whether switching
When AI Gives Contradictory Drug Advice: The Pharma Brand Risk No One Is Measuring
Ask ChatGPT whether Ozempic is safe for patients with a history of pancreatitis. Then ask Gemini. Then ask Perplexity. You
FDA Labels Are No Longer Enough: How AI Search Is Rewriting the Drug Information Layer
For decades, the FDA-approved prescribing information label was the pharmaceutical industry’s single source of truth. Physicians consulted it. Pharmacists cited
AI Search Visibility Is Now a Pharma KPI: How Drug Brands Monitor, Measure, and Win in the LLM Era
For twenty years, pharmaceutical brand teams had a reliable map of how patients found their drugs. A television ad for
AI Competitive Intelligence for Pharma: What ChatGPT, Gemini, and Perplexity Say About Your Drug
Pharmaceutical competitive intelligence used to mean analysts scraping clinical trial registries, reading SEC filings at midnight, and counting booth traffic
AI Is Manufacturing Drug Word-of-Mouth — and Most Pharma Companies Aren’t Watching
When a patient asks ChatGPT whether they should switch from Ozempic to Wegovy, the model answers. When a caregiver types